Back
ABN AMRO Bank NV Vs. Rhythm Pharmaceuticals Industry Stock Comparison
Buy
51
AAVMY
ABN AMRO Bank NV
Last Price:
$21.00
Seasonality Move:
3.58%
Buy
61
RYTM
Rhythm Pharmaceuticals
Last Price:
$64.47
Seasonality Move:
15.42%
Buy
51
ABN AMRO Bank NV (AAVMY)
is a Buy
Is ABN AMRO Bank NV a Buy, Sell or Hold?
-
The current ABN AMRO Bank NV [AAVMY] share price is $20.81. The Score for AAVMY is 51, which is 2% above its historic median score of 50, and infers lower risk than normal.
-
AAVMY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Rhythm Pharmaceuticals (RYTM)
is a Buy
Is Rhythm Pharmaceuticals a Buy, Sell or Hold?
-
The current Rhythm Pharmaceuticals [RYTM] share price is $64.41. The Score for RYTM is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
-
RYTM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
AAVMY Stock Price Chart
What is ABN AMRO Bank NV's stock price today?
-
The ABN AMRO Bank NV share price today is $20.81The current trend is moderately bullish and AAVMY is experiencing buying pressure, which is a positive indicator for future bullish movement.
RYTM Stock Price Chart
What is Rhythm Pharmaceuticals's stock price today?
-
The Rhythm Pharmaceuticals share price today is $64.41Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RYTM is experiencing buying pressure, which is a positive indicator for future bullish movement.
AAVMY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.22 | Buy |
Relative Strength Index (14 RSI): | 54.42 | Buy |
Chaikin Money Flow: | 12921 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.53 - 21.47) | Buy |
Bollinger Bands (100): | (15.68 - 20.38) | Buy |
RYTM Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 2.45 | Buy |
Relative Strength Index (14 RSI): | 64.7 | Buy |
Chaikin Money Flow: | 293034 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (52.38 - 61.8) | Buy |
Bollinger Bands (100): | (53.02 - 59.98) | Buy |
AAVMY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 20.82 | Sell |
20-day SMA: | 20.23 | Buy |
50-day SMA: | 20.16 | Buy |
200-day SMA: | 17.49 | Buy |
8-day EMA: | 20.76 | Buy |
20-day EMA: | 20.51 | Buy |
50-day EMA: | 19.84 | Buy |
200-day EMA: | 17.84 | Buy |
RYTM Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 61.72 | Buy |
20-day SMA: | 57.9 | Buy |
50-day SMA: | 55.41 | Buy |
200-day SMA: | 53.57 | Buy |
8-day EMA: | 61.88 | Buy |
20-day EMA: | 59.19 | Buy |
50-day EMA: | 56.94 | Buy |
200-day EMA: | 52.74 | Buy |
ABN AMRO Bank NV Earnings Growth & AAVMY Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.26 per share, an increase next quarter of $0.07 per share, an increase this year of $1.54 per share, and an increase next year of $1.14 per share.
ABN AMRO Bank NV Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Rhythm Pharmaceuticals Technical Analysis
Apr 14 | Apr 15 | Apr 16 | Apr 17 | Apr 21 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Apr | ||||||||||
14 | 15 | 16 | 17 | 21 | 22 | 23 | 24 | 25 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |